Cargando…
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
BACKGROUND: Allergy immunotherapy (AIT), in the form of subcutaneous immunotherapy (SCIT) with alum-precipitated aqueous extracts, SCIT with a modified ragweed pollen allergen tyrosine adsorbate (MRPATA; Pollinex(®)-R), or a sublingual immunotherapy (SLIT)-tablet are options for the treatment of rag...
Autores principales: | Ellis, Anne K., Mack, Douglas P., Gagnon, Rémi, Hammerby, Eva, Gosain, Sheena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847451/ https://www.ncbi.nlm.nih.gov/pubmed/36653868 http://dx.doi.org/10.1186/s13223-023-00758-7 |
Ejemplares similares
-
Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2021) -
Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis
por: Kim, Harold, et al.
Publicado: (2014) -
Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada
por: Ellis, Anne K., et al.
Publicado: (2021) -
Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
por: Ellis, Anne K., et al.
Publicado: (2019) -
A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option
por: Blaiss, Michael, et al.
Publicado: (2023)